Ameriprise’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Other funds holding IRON
Ameriprise's IRON Position: Q3 2026 in Review
Ameriprise increased its Disc Medicine (IRON) stake by 156% in Q3 2026, buying an estimated $5.42M and bringing the position to 117,643 shares worth $7.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2210.
Ameriprise first reported a position in IRON in Q4 2024 and has held it in 8 quarters since. 236 funds tracked by Wall St. Rank hold IRON as of Q3 2026.
- Ameriprise held 117,643 shares of Disc Medicine worth $7.7M as of Q3 2026.
- Ameriprise bought 71,769 Disc Medicine shares in Q3 2026, an estimated $5.42M.
- Disc Medicine made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #2210 holding.
- Ameriprise first reported a position in Disc Medicine in Q4 2024 and has held it in 8 quarters since.
- 236 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.